# US 2021/0233616 A1 · A Streamlined Method for Analytical Validation of Biochemicals Detected Using an Untargeted Mass-Spectrometry Platform

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0233616 A1
- Document ID: US20210233616A1
- Status: Published application
- Kind: A1
- Application number: 16/647,883
- Filed: 2018-10-04
- Published: 2021-07-29
- Earliest claimed: 2018-10-04
- Assignees: Metabolon, Inc.
- Applicants: Metabolon, Inc.
- Inventors: Adam D. KENNEDY
- Web page: https://patentgrep.com/patent/US20210233616A1

## CPC

- G16B 40/10: Signal processing, e.g. from mass spectrometry [MS] or from PCR
- G16C 20/20: Identification of molecular entities, parts thereof or of chemical compositions
- H01J 49/0036: {Step by step routines describing the handling of the data generated during a measurement}
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)

## Abstract

A method of assessing the analytical performance of a biochemical measured using a multi-analyte assay is described. The method includes analytically validating a measurement of the level of a first biochemical in a sample, wherein the first biochemical has been previously analytically validated for three or more analytical validation conditions; measuring the level of a second biochemical in a sample, wherein the second biochemical is structurally or biochemically related to the first biochemical; and comparing validation parameters of the first biochemical with validation parameters of the second biochemical to determine whether the performance of the second biochemical is acceptable based on the comparison results.

## Claims

### Claim at position 1

1-49. (canceled)

### Claim 50

A method of assessing the analytical performance of a biochemical measured using a multi-analyte assay, the method comprising:
a) analytically validating the measurements of the level of a first biochemical in a sample, wherein the first biochemical is analytically validated for three or more analytical validation conditions selected from the group consisting of: Intra-day Precision, Inter-day Precision, Linearity, Limit of Detection/Quantitation, Matrix effect, Exogenous interference, Carryover, Recovery, Stability or Correlation with standard clinical assays;
b) measuring the level of a second biochemical in a sample, wherein the second biochemical is structurally or biochemically related to the first biochemical;
c) for the second biochemical, selecting one or more of the three or more analytical validation conditions;
d) calculating one or more performance value(s) for the selected one or more analytical validation conditions for the second biochemical based on the measured level of the second biochemical;
e) comparing the calculated one or more performance value(s) for the selected one or more analytical validation conditions for the second biochemical to an acceptance criterion for the three or more analytical validation conditions for the first biochemical; and
f) determining the analytical performance of the second biochemical to be acceptable if the calculated one or more performance value(s) of the second biochemical meets the acceptance criterion for the three or more analytical validation conditions for the first biochemical; and
g) determining the analytical performance of the second biochemical to be unacceptable if the calculated one or more performance value(s) of the second biochemical does not meet the acceptance criterion for the three or more analytical validation conditions for the first biochemical.

### Claim 51 (depends on 50)

The method of claim 50, wherein the multi-analyte assay comprises mass spectrometry.

### Claim 52 (depends on 50)

The method of claim 50, wherein the multi-analyte assay comprises liquid chromatography and mass spectrometry.

### Claim 53 (depends on 50)

The method of claim 50, wherein the one or more performance values for the one or more analytical validation conditions are calculated using correlation analysis (R2), % fill, % Systematic Error (SE), % Bias, % Difference, or % Coefficient of Variation (CV).

### Claim 54 (depends on 53)

The method of claim 53, wherein one of the one or more analytical validation conditions is selected from the group consisting of intra-day precision or inter-day precision and a performance value of 30% CV or less meets the acceptance criterion.

### Claim 55 (depends on 50)

The method of claim 50, wherein two analytical validation conditions are selected for the second biochemical.

### Claim 56 (depends on 55)

The method of claim 55, wherein the two analytical validation conditions are intra-day (single day) precision and inter-day (multi-day) precision.

### Claim 57

A method of assessing the analytical performance of a biochemical measured using a multi-analyte assay, the method comprising:
a) measuring the level of a biochemical in a sample, wherein the biochemical is structurally or biochemically related to one or more biochemicals that were previously fully analytically validated;
b) selecting one or more analytical validation conditions from the group comprising single-day precision (intra-day precision), multi-day precision (inter-day precision), limit of detection/quantitation (LOD/LOQ), linearity, stability, carryover, matrix effect, biochemical recovery, interference, or correlation with standard clinical assays;
c) calculating one or more performance value(s) for the selected one or more analytical validation conditions for the biochemical based on the measured level of the biochemical in the sample;
d) comparing the calculated one or more performance value(s) for the one or more analytical validation conditions for the biochemical to an acceptance criterion for the one or more analytical validation conditions for the previously validated one or more biochemicals; and
e) determining the analytical performance of the biochemical to be either acceptable, if it meets the acceptance criterion, or unacceptable, if it does not meet the acceptance criterion, for the corresponding analytical validation condition.

### Claim 58 (depends on 57)

The method of claim 57, wherein the multi-analyte assay comprises mass spectrometry.

### Claim 59 (depends on 57)

The method of claim 57, wherein the multi-analyte assay comprises liquid chromatography and mass spectrometry

### Claim 60 (depends on 57)

The method of claim 57, wherein the one or more performance values for the one or more analytical validation conditions are calculated using correlation analysis (R2), % fill, % Systematic Error (SE), % Bias, % Difference, or % Coefficient of Variation (CV).

### Claim 61 (depends on 60)

The method of claim 60, wherein one of the one or more analytical validation conditions is selected from the group consisting of intra-day precision or inter-day precision and a performance value of 30% CV or less meets the acceptance criterion.

### Claim 62 (depends on 57)

The method of claim 57, wherein two analytical validation conditions are selected.

### Claim 63 (depends on 62)

The method of claim 62 wherein the two analytical validation conditions are intra-day (single day) precision and inter-day (multi-day) precision.

### Claim 64

A method of assessing the analytical performance of a biochemical measured using a multi-analyte assay, the method comprising:
a) analytically validating the measurements of the level of a first biochemical in a sample, wherein the first biochemical is analytically validated for three or more analytical validation conditions selected from the group consisting of: Intra-day Precision, Inter-day Precision, Linearity, Limit of Detection, Matrix effect, Exogenous interference, Carryover, or correlation with standard clinical assays;
b) measuring the level of a second biochemical in a sample, wherein the second biochemical is structurally or biochemically related to the first biochemical;
c) calculating one or more performance value(s) for one or more of the selected three or more analytical validation conditions for the first biochemical based on the measured level of the first biochemical;
d) for the second biochemical, calculating one or more performance value(s) for the one or more of the selected three or more analytical validation conditions based on the measured level of the second biochemical;
e) comparing the calculated one or more performance value(s) for the analytical validation conditions for the first biochemical with the calculated one or more performance value(s) for the analytical validation conditions for the second biochemical;
f) determining the performance of the second biochemical to be acceptable if the calculated one or more performance value(s) for the second biochemical are within 50% of the calculated one or more performance value(s) for the first biochemical; and
f) determining the performance of the second biochemical to be unacceptable if the calculated one or more performance value(s) for the second biochemical are not within 50% of the calculated one or more performance value(s) for the first biochemical.

### Claim 65 (depends on 64)

The method of claim 64, wherein the one or more performance values for the three or more analytical validation conditions comprise % fill and/or % CV.

### Claim 66 (depends on 64)

The method of claim 64, wherein two of the three or more analytical validation conditions are intra-day (single day) precision and inter-day (multi-day) precision.

### Claim 67 (depends on 64)

The method of claim 64, wherein the assay comprises mass spectrometry.

### Claim 68 (depends on 64)

The method of claim 64, wherein the assay comprises liquid chromatography and mass spectrometry
